“I couldn’t be more excited to be a part of this team and to join a Company whose rich history and people I’ve known and admired during a career in drug discovery and development,” said Dr. Daniels. “When I think about the Company’s forward momentum and broad spectrum of scientific expertise, I know that our integrated drug metabolism and pharmacokinetic division will strengthen the Company’s capabilities for supporting drug safety and pharmacology studies and helping our clients reach their goals.”